NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis

Lupus

Volumn 22, Issue 13, 2013, Pages 1361-1370

  Oates, J C ^a,c   Mashmoushi, A K ^a   Shaftman, S R ^b   Gilkeson, G S ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

endothelial nitric oxide synthase; inflammation; Lupus nephritis; NADPH oxidase; nitric oxide; oxidation reduction; proliferative lupus nephritis; superoxide; systemic lupus erythematosus

Indexed keywords

HEMOGLOBIN A1C; NITRIC OXIDE SYNTHASE; PLASMA PROTEIN; PREDNISONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ADULT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY BIOPSY; KIDNEY CORTEX; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROLIFERATIVE LUPUS NEPHRITIS; PROTEIN MODIFICATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INFLAMMATION; LUPUS NEPHRITIS; NADPH OXIDASE; NITRIC OXIDE; OXIDATION-REDUCTION; PROLIFERATIVE LUPUS NEPHRITIS; SUPEROXIDE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANIMALS; BIOPSY; BLOOD PROTEINS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; HUMANS; KIDNEY CORTEX; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED MRL LPR; MICE, KNOCKOUT; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE III; PROSPECTIVE STUDIES; SUPEROXIDES; TYROSINE; UP-REGULATION; YOUNG ADULT;

EID: 84887117984     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313507988     Document Type: Article

References (49)

1. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004 ; 65: 521-530
2. Dooley MA, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int. 1997 ; 51: 1188-1195
3. Oates JC, Christensen EF, Reilly CM, Self SE, Gilkeson GS. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity. Proc Assoc Am Phys. 1999 ; 111: 611-621
4. Furusu A, Miyazaki M, Abe K, et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int. 1998 ; 53: 1760-1768
5. Oates JC, Shaftman SR, Self SE, Gilkeson GS. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum. 2008 ; 58: 263-272
6. Njoku C, Self SE, Ruiz P, Hofbauer AF, Gilkeson GS, Oates JC. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene. J Investig Med. 2008 ; 56: 911-919
7. Gilkeson GS, Mudgett JS, Seldin MF, et al. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med. 1997 ; 186: 365-373
8. Njoku CJ, Patrick KS, Ruiz P, Oates JC. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. J Investig Med. 2005 ; 53: 347-352
9. Janssen-Heininger YM, Mossman BT, Heintz NH, et al. Redox-based regulation of signal transduction: Principles, pitfalls, and promises. Free Radic Biol Med. 2008 ; 45: 1-17
10. Fiebeler A, Park JK, Muller DN, et al. Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases. Am J Kidney Dis. 2004 ; 43: 286-295
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
12. Austin HA, 3rd, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med. 1983 ; 75: 382-391
13. Austin HA, 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int. 1984 ; 25: 689-695
14. Hensley K, Williamson KS, Floyd RA. Measurement of 3-nitrotyrosine and 5-nitro-gamma-tocopherol by high-performance liquid chromatography with electrochemical detection. Free Radic Biol Med. 2000 ; 28: 520-528
15. Crowley JR, Yarasheski K, Leeuwenburgh C, Turk J, Heinecke JW. Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine. Anal Biochem. 1998 ; 259: 127-135
16. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell. 1996 ; 85: 311-318
17. Vidal S, Kono DH, Theofilopoulos AN. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J Clin Invest. 1998 ; 101: 696-702
18. Watson ML, Rao JK, Gilkeson GS, et al. Genetic analysis of MRL-lpr mice: Relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992 ; 176: 1645-1656
19. Gilkeson GS, Mashmoushi AK, Ruiz P, Caza TN, Perl A, Oates JC. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. PLoS ONE. 2013 ; 8: e64650 - e64650
20. Hagiwara M, Bledsoe G, Yang ZR, Smith RS, Jr., Chao L, Chao J. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. Am J Physiol Renal Physiol. 2008 ; 295: F1735 - F1743
21. Gupte SA, Levine RJ, Gupte RS, et al. Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. J Mol Cell Cardiol. 2006 ; 41: 340-349
22. Gilkeson GS, Mashmoushi AK, Ruiz P, Caza TN, Perl A, Oates JC. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. PloS One. 2013 ; 8: e64650 - e64650
23. Moroni G, Novembrino C, Quaglini S, et al. Oxidative stress and homocysteine metabolism in patients with lupus nephritis. Lupus. 2010 ; 19: 65-72
24. Nishikawa M, Igarashi R, Nakazawa T, Aikawa E. Rescue of (NZB × NZW) F1 mice from oxygen-derived free radical injury by use of phosphatidylcholine-modified superoxide dismutase. Lab Anim Sci. 1999 ; 49: 560-564
25. Suwannaroj S, Lagoo A, Keisler D, McMurray RW. Antioxidants suppress mortality in the female NZB × NZW F1 mouse model of systemic lupus erythematosus (SLE). Lupus. 2001 ; 10: 258-265
26. Cooke MS, Mistry N, Wood C, Herbert KE, Lunec J. Immunogenicity of DNA damaged by reactive oxygen species - implications for anti-DNA antibodies in lupus. Free Radic Biol Med. 1997 ; 22: 151-159
27. Griffiths HR. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?. Autoimmun Rev. 2008 ; 7: 544-549
28. Weinberg JB, Granger DL, Pisetsky DS, et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L- arginine. J Exp Med. 1994 ; 179: 651-660
29. Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007 ; 7: 803-815
30. Shah D, Wanchu A, Bhatnagar A. Interaction between oxidative stress and chemokines: Possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology. 2011 ; 216: 1010-1017
31. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal. 2005 ; 7: 395-403
32. Brunner HI, Bennett MR, Mina R, et al. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum. 2012 ; 64: 2687-2697
33. Li Y, Tucci M, Narain S, et al. Urinary biomarkers in lupus nephritis. Autoimmun Rev. 2006 ; 5: 383-388
34. Kiberd BA. Interleukin-6 receptor blockage ameliorates murine lupus nephritis. J Am Soc Nephrol. 1993 ; 4: 58-61
35. Kulkarni O, Pawar RD, Purschke W, et al. Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice. J Am Soc Nephrol. 2007 ; 18: 2350-2358
36. Wada T, Yokoyama H, Su SB, et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int. 1996 ; 49: 761-767
37. Marks SD, Williams SJ, Tullus K, Sebire NJ. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis. Nephrol Dial Transplant. 2008 ; 23: 3521-3526
38. Champion ChiP Transcription Factor Search Portal 2012. Available from: http://www.sabiosciences.com/chipqpcrsearch.php?app=TFBS (accessed 27 December 2012).
39. Volk T, Hensel M, Schuster H, Kox WJ. Secretion of MCP-1 and IL-6 by cytokine stimulated production of reactive oxygen species in endothelial cells. Mol Cell Biochem. 2000 ; 206: 105-112
40. Bendall JK, Alp NJ, Warrick N, et al. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: Insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res. 2005 ; 97: 864-871
41. Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003 ; 111: 1201-1209
42. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev. 2007 ; 87: 245-313
43. Pricop L, Gokhale J, Redecha P, Ng SC, Salmon JE. Reactive oxygen intermediates enhance Fc gamma receptor signaling and amplify phagocytic capacity. J Immunol. 1999 ; 162: 7041-7048
44. Sumiyoshi K, Mokuno H, Iesaki T, et al. Deletion of the Fc receptors gamma chain preserves endothelial function affected by hypercholesterolaemia in mice fed on a high-fat diet. Cardiovasc Res. 2008 ; 80: 463-470
45. Stielow C, Catar RA, Muller G, et al. Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. Biochem Biophys Res Commun. 2006 ; 344: 200-205
46. Selemidis S, Dusting GJ, Peshavariya H, Kemp-Harper BK, Drummond GR. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc Res. 2007 ; 75: 349-358
47. Pleskova M, Beck KF, Behrens MH, et al. Nitric oxide down-regulates the expression of the catalytic NADPH oxidase subunit Nox1 in rat renal mesangial cells. FASEB J. 2006 ; 20: 139-141
48. Kiss E, Soltesz P, Der H, et al. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. J Autoimmun. 2006 ; 27: 211-217
49. Ahmadzadehfar H, Oguogho A, Efthimiou Y, Kritz H, Sinzinger H. Passive cigarette smoking increases isoprostane formation. Life Sci. 2006 ; 78: 894-897